Challenges in IBD Research: Environmental Triggers. (16th May 2019)

• Record Type: Journal Article
• Authors: Ho, Shuk-Mei; Lewis, James D; Mayer, Emeran A; Plevy, Scott E; Chuang, Emil; Rappaport, Stephen M; Croitoru, Kenneth; Korzenik, Joshua R; Krischer, Jeffrey; Hyams, Jeffrey S; Judson, Richard; Kellis, Manolis; Jerrett, Michael; Miller, Gary W; Grant, Melanie L; Shtraizent, Nataly; Honig, Gerard; Hurtado-Lorenzo, Andrés; Wu, Gary D
• Is Part Of: Inflammatory bowel diseases. Volume 25(2019)Supplement 2
• Page Start: S13
• Page End: S23
• Publication Date: 2019-05-16
• Subjects: Crohn's disease -- ulcerative colitis -- environment -- exposome -- smoking -- antibiotic -- virus -- pollutant -- diet -- epidemiology -- in silico modeling; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izz076
• Languages: English
• ISSNs: 1078-0998

Abstract

Abstract: Environmental triggers is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, novel technologies, precision medicine and pragmatic clinical research. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD) research and delivers actionable approaches to address them. It is the result of a multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient centric research prioritization. In particular, the environmental triggers section is focused on the main research gaps in elucidating causality of environmental factors in IBD. Research gaps were identified in: 1) epidemiology of exposures; 2) identification of signatures of biological response to exposures; and 3) mechanisms of how environmental exposures drive IBD. To address these gaps, the implementation of longitudinal prospective studies to determine disease evolution and identify sub-clinical changes in response to exposures is proposed. This can help define critical windows of vulnerability and risk prediction. In addition, systems biology analysis and in silico modeling were proposed as approaches to integrate the IBD exposome for the identification of biological signatures of response to exposures, and to develop prediction models of the effects of environmental factors in driving disease activity and response to therapy. This research could lead to identification of biomarkers of exposures and new modalities for therapeutic intervention. Finally, hypothesis-driven mechanistic studies to understand gene-environment interactions and to validate causality of priority factors should be performed to determine how environment influences clinical outcomes. Abstract : This section is focused on the main research gaps and approaches in elucidating causality of environmental factors in IBD, including epidemiology of exposures, identification of signatures of biological response to exposures, and mechanisms of how environmental exposures drive IBD.